Protecting hope: situation analysis of vulnerable children in Uganda
The Government of Uganda (GOU) has focused attention on the problem of orphaned and other vulnerable children (OVC) through a number of policies, regulations, and initiatives.
The Government of Uganda (GOU) has focused attention on the problem of orphaned and other vulnerable children (OVC) through a number of policies, regulations, and initiatives.
This report is based on research and interviews conducted by the Center between June 2009 and February 2010. The Center gathered the experiences of 59 women through a combination of in-depth interviews and focus group discussions.
This study assesses trends in the prevalence and status of orphans and vulnerable children (OVC) based on data from 2005-06, 1999, and 1994 Zimbabwe Demographic and Health Surveys (ZDHS).
The purpose of the study summarised in this document was to determine the roles of educators in mitigating the impact of the HIV/AIDS pandemic, and to ascertain the skills and knowledge required by them to play such roles effectively.
The broad objectives of this study are to obtain HIV prevalence statistics and HIV behavioural response profiles of staff and students in higher education in South Africa.
This updated review will focus on interventions carried out and/or published from January 2005 - December 2008. Since the first Steady, Ready, Go!
The catastrophe of HIV/AIDS (human immunodeficiency virus/acquired immune deficiency syndrome) in Africa, which has already claimed over 18 million lives on that continent, has hit girls and women harder than boys and men.
This paper focuses on the socio-cultural context in which the enactment of "high-risk" youth sexual activity takes place.
This paper summarises the present situation in terms of African universities and their response to HIV/AIDS and lists examples of good practice.
The HIV epidemic, which has spread rapidly through much of Sub-Saharan Africa, has emerged as one of the greatest threats to human development in South Africa. HIV seroprevalence among pregnant women has increased from less than 2% in 1992 to 22.4% in 19991.